AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,890,000 | -2.7% | 1,000,000 | 0.0% | 1.38% | +1.4% |
| Q2 2023 | $71,860,000 | -35.7% | 1,000,000 | -39.6% | 1.36% | -24.3% |
| Q2 2021 | $111,676,000 | +19.1% | 1,655,447 | 0.0% | 1.79% | +26.8% |
| Q1 2021 | $93,731,000 | -30.5% | 1,655,447 | 0.0% | 1.41% | -25.0% |
| Q4 2020 | $134,869,000 | -7.0% | 1,655,447 | -18.7% | 1.88% | -28.9% |
| Q3 2020 | $145,003,000 | -13.4% | 2,035,132 | 0.0% | 2.65% | -18.7% |
| Q2 2020 | $167,451,000 | +49.5% | 2,035,132 | +6.9% | 3.26% | -7.8% |
| Q1 2020 | $112,018,000 | +194.7% | 1,904,094 | +417.7% | 3.54% | +206.9% |
| Q4 2019 | $38,017,000 | +182.7% | 367,816 | -44.6% | 1.15% | +43.9% |
| Q3 2019 | $13,447,000 | -61.1% | 664,385 | -50.4% | 0.80% | -56.8% |
| Q2 2019 | $34,526,000 | -26.3% | 1,340,828 | -59.3% | 1.85% | -8.3% |
| Q1 2019 | $46,871,000 | – | 3,293,789 | – | 2.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |